Perrigo | PRGO - 負債





負債 変化する 日付
AbbVie USD 72.86B 5.36B 2026-03
Abbott USD 34.05B 20.19B 2026-03
Bayer EUR 36.45B 2.93B 2025-12
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Corcept Therapeutics USD 9.64M 3.53M 2026-03
Dr.Reddys Laboratories INR 71.95B 5.39B 2026-06
Eli Lilly USD 43.37B 867M 2026-03
J&J USD 54.99B 7.05B 2026-03
Merck USD 49.12B 222M 2026-03
Nestle CHF 57.85B 3.54B 2025-12
Pacira USD 363.12M 4.53M 2026-06
Perrigo USD 3.63B 7.7M 2026-03
Pfizer USD 63.19B 536M 2026-06
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.05B 33.86M 2026-03
Reckitt Benckiser GBP 8.66B 238M 2024-12
Sanofi EUR 23.58B 3.56B 2026-06
Supernus Pharmaceuticals USD 40.17M 733K 2026-06
Teva Pharmaceutical Industries USD 16.91B 187M 2026-03
Xeris Pharmaceuticals USD 258.55M 899K 2026-03
Zoetis USD 9.24B 0 2026-03